If investors want better outcomes, they would be better served if capital were allocated by diverse teams. And the issue is not just about white males. When a team or market is dominated by any ethnicity, it tends to make worse decisions.
The issue of transparency in healthcare, particularly where pricing and payment information is concerned, has been widely debated for years. Is there a benefit to making this information readily available to the general public?
Only if you know where to shop, goes the old punch line. But a recent Wall Street Journal article cites new research on the long-argued subject that is worth riffing upon.